HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

11th Edition of World Nanotechnology Conference

March 23-25, 2026

March 23 -25, 2026 | Singapore

Drug Development

Drug Development

Drug development is a multifaceted process crucial for introducing new pharmaceuticals into the market. It encompasses a series of stages, starting with initial drug discovery and culminating in regulatory approval and commercialization. The journey begins with identifying potential drug candidates, often through extensive research and screening processes. Once a promising compound is identified, preclinical testing evaluates its safety and efficacy in laboratory settings. Successful candidates progress to clinical trials, where their performance is assessed in human subjects. Clinical trials are conducted in phases, each providing essential insights into the drug's safety profile, dosage, and effectiveness. Regulatory agencies closely scrutinize these results before granting approval for marketing. Post-approval monitoring ensures ongoing safety evaluation, addressing any emerging concerns.

Drug development is marked by collaboration among researchers, clinicians, regulatory authorities, and pharmaceutical companies. It requires substantial financial investments, often spanning several years. Despite the challenges, successful drug development has transformative effects on healthcare, providing innovative solutions for various medical conditions and improving patient outcomes.

Committee Members
Speaker at World Nanotechnology Conference 2026 - Harry E Ruda

Harry E Ruda

University of Toronto, Canada
Speaker at World Nanotechnology Conference 2026 - Paulo Cesar De Morais

Paulo Cesar De Morais

Catholic University of Brasilia, Brazil
Speaker at World Nanotechnology Conference 2026 - Raman Singh

Raman Singh

Monash University, Australia

Submit your abstract Today

Watsapp